Pfizer is running tests to determine if its covid vaccine is effective against the new variant
German laboratory Biotechnology Study urgently The effectiveness of the COVID-19 vaccine developed by Pfizer To see if it protects from New variant B.1.1.529 discovered in South Africa.
“We expect more data from lab tests within two weeks at the most,” a spokesperson said.
He added, “These data will provide more information on whether B.1.1.529 could be a variant that may require our vaccine to be modified if the variant spreads globally.”
The Discover this new alternative by South African scientists unleashed global anxiety, amid fears that Several mutations may make it more dangerous than the delta variant, very contagious.
After the announcement, several countries – including the UK, Italy and Germany – decided to Closed its doors to travelers from different countries of South Africa.
According to BioNTech, the B.1.1.529 variant “is distinctly different from variants already known because it contains additional mutations in the spike protein.”
A laboratory spokesperson stressed that “Pfizer and BioNTech prepared several months ago to modify their vaccine in less than six weeks and deliver the first doses in 100 days” if the alternative proves to be resistant.
“Travel enthusiast. Alcohol lover. Friendly entrepreneur. Coffeeaholic. Award-winning writer.”